Glen R. Hanson

Glen R. Hanson, DDS, PhD

Languages spoken: English

Academic Office Information

Glen.Hanson@hsc.utah.edu

Research Interests

  • Neurochemistry
  • Neuropeptides
  • Excitatory Amino Acids
  • Ganglia, Sensory
  • Substance P
  • Receptors, Dopamine
  • Microdialysis
  • Glutamates
  • Norepinephrine
  • Free Radicals
  • Cardiac Electrophysiology
  • Monoamines
  • Cholinergic Transmitter Systems
  • Antipsychotics
  • Stimulants of Abuse
  • Cholinergic Ligands
  • Serotonergic Ligands
  • Transmitter Release
  • Plasmalemmal and Vesicular Transporters

Education History

Postdoctoral Fellowship National Institutes of Health (National Heart, Lung and Blood Institute)
 Postdoctoral Fellow
Doctoral Training University of Utah
 PhD
Professional Dental University of California at Los Angeles
 DDS
Undergraduate Brigham Young University

Selected Publications

Journal Article

  1. Comba P, Eisenschmidt A, Gahan LR, Hanson GR, Mehrkens N, Westphal M (2016). Dinuclear ZnII and mixed CuII-ZnII complexes of artificial patellamides as phosphatase models. Dalton Trans, 45(47), 18931-18945. (Read full article)
  2. Kilmartin JR, Bernhardt PV, Dhouib R, Hanson GR, Riley MJ, Kappler U (2016). Effects of mutations in active site heme ligands on the spectroscopic and catalytic properties of SoxAX cytochromes. J Inorg Biochem, 162, 309-318. (Read full article)
  3. Pittenger ST, Swalve N, Chou S, Smith MD, Hoonakker AJ, Pudiak CM, Fleckenstein AE, Hanson GR, Bevins RA (2016). Sex differences in neurotensin and substance P following nicotine self-administration in rats. Synapse, 70(8), 336-46. (Read full article)
  4. Baladi MG, Nielsen SM, McIntosh JM, Hanson GR, Fleckenstein AE (2016). Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors. Behav Pharmacol, 27(5), 422-30. (Read full article)
  5. Barak LS, Bai Y, Peterson S, Evron T, Urs NM, Peddibhotla S, Hedrick MP, Hershberger P, Maloney PR, Chung TD, Rodriguiz RM, Wetsel WC, Thomas JB, Hanson GR, Pinkerton AB, Caron MG (2016). ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse. ACS Chem Biol, 11(7), 1880-90. (Read full article)
  6. Fricks-Gleason AN, German CL, Hoonakker AJ, Friend DM, Ganesh KK, Carver AS, Hanson GR, Fleckenstein AE, Keefe KA (2016). An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity. Synapse, 70(4), 139-46. (Read full article)
  7. Jones CE, Zandawala M, Semmens DC, Anderson S, Hanson GR, Janies DA, Elphick MR (2016). Identification of a neuropeptide precursor protein that gives rise to a "cocktail" of peptides that bind Cu(II) and generate metal-linked dimers. Biochim Biophys Acta, 1860(1 Pt A), 57-66. (Read full article)
  8. McGrath AP, Laming EL, Casas Garcia GP, Kvansakul M, Guss JM, Trewhella J, Calmes B, Bernhardt PV, Hanson GR, Kappler U, Maher MJ (2015). Structural basis of interprotein electron transfer in bacterial sulfite oxidation. Elife, 4, e09066. (Read full article)
  9. Bosch S, Comba P, Gahan LR, Hanson GR, Noble C, Schenk G, Wadepohl H (2015). Selective Coordination of Gallium(III), Zinc(II), and Copper(II) by an Asymmetric Dinucleating Ligand: A Model for Metallophosphatases. Chemistry, 21(50), 18269-79. (Read full article)
  10. Rienecker SB, Mostert AB, Schenk G, Hanson GR, Meredith P (2015). Heavy Water as a Probe of the Free Radical Nature and Electrical Conductivity of Melanin. J Phys Chem B, 119(48), 14994-5000. (Read full article)
  11. Vieira-Brock PL, McFadden LM, Nielsen SM, Ellis JD, Walters ET, Stout KA, McIntosh JM, Wilkins DG, Hanson GR, Fleckenstein AE (2015). Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits. J Pharmacol Exp Ther, 355(3), 463-72. (Read full article)
  12. Bernhardt PV, Bosch S, Comba P, Gahan LR, Hanson GR, Mereacre V, Noble CJ, Powell AK, Schenk G, Wadepohl H (2015). An Approach to More Accurate Model Systems for Purple Acid Phosphatases (PAPs). Inorg Chem, 54(15), 7249-63. (Read full article)
  13. Alburges ME, Hoonakker AJ, Cordova NM, Robson CM, McFadden LM, Martin AL, Hanson GR (2015). Effect of low doses of methamphetamine on rat limbic-related neurotensin systems. Synapse, 69(8), 396-404. (Read full article)
  14. Vieira-Brock PL, McFadden LM, Nielsen SM, Smith MD, Hanson GR, Fleckenstein AE (2015). Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits.LID - 10.1093/ijnp/pyv073 [doi]LID - pyv073 [pii]. Int J Neuropsychopharmacol, 18(12). (Read full article)
  15. McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE (2015). Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure. Neuropharmacology, 93, 146-54. (Read full article)
  16. Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR (2015). Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment. Drug Alcohol Depend, 146, 30-8. (Read full article)

Review

  1. German CL, Baladi MG, McFadden LM, Hanson GR, Fleckenstein AE (2015). Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. [Review]. Pharmacol Rev, 67(4), 1005-24. (Read full article)